Shaping Biomedicine as an Information Science

July 7, 2019

https://web.stanford.edu/dept/HPS/TimLenoir/shapingbiomedicine.html
QT:{{”
To provide commercial users with their own unrestricted access to GENET and MOLGEN programs, Brutlag, Feigenbaum, Friedland, and Kedes formed a company, IntelliGenetics, which would offer the suite of MOLGEN software for sale or rental to the emerging biotechnology industry. With 125 research labs doing recombinant DNA research in the US alone and a number of new genetic engineering firms starting up, opportunities looked outstanding. No one was currently supplying software in this rapidly growing genetic engineering marketplace. With their exclusive licensing arrangement with Stanford for the MOLGEN software, IntelliGenetics was poised to lead a huge growth area. The business plan expressed well the excellent position of the company: “}}

This entry was posted on July 7, 2019 at 2:42 pm and is filed under -.

Tags: ,